Incannex
Helping a newly NASDAQ-listed Australian biotech build its U.S. presence.
Our challenge and opportunity
Recently redomiciled in the U.S., Incannex’s leadership needed a rapid yet strategic corporate relaunch to raise visibility with its NASDAQ presence.
An agile, 10-week project using our ALIGN Methodology™ repositioned Incannex as a clinically rigorous biotech and unified their three lead assets under a clear strategic narrative. Coupled with a new visual system, the new brand debuted on a user-friendly, dynamic new website.
An agile, 10-week project using our ALIGN Methodology™ repositioned Incannex as a clinically rigorous biotech and unified their three lead assets under a clear strategic narrative. Coupled with a new visual system, the new brand debuted on a user-friendly, dynamic new website.
What we did
Research and competitive analysis
Brand strategy and positioning
Visual identity development, brand and business system
Corporate website
Brand imagery library
Brand strategy and positioning
Visual identity development, brand and business system
Corporate website
Brand imagery library
Waterhouse’s market landscape analysis and interviews uncovered an insight to lean into the company’s innovative approach and combination medicines strategy. Their new tagline: Innovating new pathways to relief.
Incannex’s new logo and brand icon signaled two medicines coming together, to emphasize the company’s combination medicines strategy.
The visual identity system and graphic elements were extended across business materials like their corporate PPT.
An agile and accelerated website build brought the new strategy and the visual brand together.
“Waterhouse delivered across all aspects of our rebrand - from messaging and creative to project and timeline management. We are very grateful to everyone at Waterhouse who worked to make this project a success.”
Joel Latham
CEO, Incannex
